- Home
- FGNX vs ORMP Comparison
FGNX vs ORMP Comparison
Compare FGNX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FGNX | ORMP |
|---|---|---|
| Founded | 1932 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.4M | 134.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FGNX | ORMP |
|---|---|---|
| Price | $1.72 | $3.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 463.6K | 290.9K |
| Earning Date | 03-26-2026 | 03-26-2026 |
| Dividend Yield | N/A | ★ 7.69% |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | ★ $17,450,000.00 | $2,000,000.00 |
| Revenue This Year | $95.83 | N/A |
| Revenue Next Year | $42.41 | N/A |
| P/E Ratio | ★ N/A | $3.16 |
| Revenue Growth | ★ 144.71 | N/A |
| 52 Week Low | $1.59 | $1.82 |
| 52 Week High | $41.25 | $3.71 |
Technical Indicators
Market Signals| Indicator | FGNX | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 25.03 | 45.56 |
| Support Level | $1.59 | $3.21 |
| Resistance Level | $2.98 | $3.51 |
| Average True Range (ATR) | 0.18 | 0.16 |
| MACD | -0.10 | -0.04 |
| Stochastic Oscillator | 9.22 | 5.13 |
Price Performance
Historical ComparisonAbout FGNX Fundamental Global Inc.
FG Nexus Inc is a capital markets platform focused on long-term Ethereum (ETH) accumulation and on-chain yield generation. The company provides institutional investors with secure, regulated access to ETH as a productive reserve asset, generating native staking yield while underpinning stablecoins, tokenized assets, and AI-driven applications.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.